Why the study?
Neurostimulation is routinely used for chronic pain but remains underutilized for managing pain and other symptoms relating to cardiovascular dysfunctions.
Does spinal cord stimulation improve symptoms and quality of life in patients with refractory angina pectoris and critical limb ischemia?
Does spinal cord stimulation improve symptoms and quality of life in patients with refractory angina pectoris and critical limb ischemia?
Spinal cord stimulation is an effective, safe, and minimally invasive option for managing ischemic pain in patients with refractory angina and critical limb ischemia.
Answers are grounded in this paper and cite their sources.
May support SCS consideration for refractory ischemic pain; leaves open need for RCTs to confirm efficacy before practice change.
Introduction: The algorithmic use of neurostimulation to treat chronic pain is routine. However, it is underutilized in managing pain and other symptoms relating to cardiovascular dysfunctions. The goal of this article is to focus on the clinical results from using spinal cord stimulation (SCS) in the realm of cardiovascular medicine. Material and Methods: The current literature was reviewed, summarized and tabulated. This manuscript contains results from systematic reviews, randomized clinical trials and observational study search results on PubMed spanning the last 30 years. The official positioning statement from the International Neuromodulation Society Neuromodulation Appropriateness Consensus Committee (NACC) was also highlighted. Results: Evidence supports that SCS is asafe, reversible, minimally-invasive and efficacious modality to mitigate chronic symptoms of refractory angina pectoris and critical limb ischemia. Discussion: Spinal cord stimulation is effective in providing relief, improve quality of life and functional mobility in patients living with ischemic pain of systemic arterial occlusive disease. Conclusion: Spinal cord stimulation should be considered early in the treatment algorithm among individuals with inoperable ischemic pain.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: